有媒体援引知情人士透露,美国食品药品监督管理局(FDA)官员已通知默克、赛诺菲和阿斯利康,其呼吸道合胞病毒抗体疗法将接受新一轮安全性评估。
有媒体援引知情人士透露,美国食品药品监督管理局(FDA)官员已通知默克、赛诺菲和阿斯利康,其呼吸道合胞病毒抗体疗法将接受新一轮安全性评估。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.